Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 31/5/2020
SIETES contiene 93020 citas

 1 a 20 de 21 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Phillips AN, Gazzard BG, Clumeck N, Losso MH, Lundgren JD. When should antiretroviral therapy for HIV be started?. BMJ 2007;334:76-8. [Ref.ID 78867]
2. Cita con resumen
Campbell OMR, Graham WJ, on behalf of The Lancet Maternal Survival Series steering group. Strategies for reducing maternal mortality: getting on with what works. Lancet 2006;368:1284-99. [Ref.ID 78143]
3. Cita con resumen
Ananworanich J, Gayet-Ageron A, Le Braz M, Prasithsirikul W, Chetchotisakd P, Kiertiburanakul S, Munsakul W, Raksakulkam P, Transuphasawasdikul S, Sirivichayakul S, Cavassini M, Karrer U, Genné D, Nüesch R, Vernazza P, Bernasconi E, Leduc D, Satchell C, Yerly S, Perrin L, Hill A, Perneger T, Phanuphak P, Furrer H, Cooper D, Ruxruntham K, Hirschel B, The Staccato Study Group, The Swiss HIV Cohort Study. CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of Staccato randomised trial. Lancet 2006;368:459-65. [Ref.ID 77654]
4.Tiene citas relacionadas Cita con resumen
Danel C, Moh R, Minga A, Anzian A, Ba-Gomis O, Kanga C, Nzunetu G, Gabillard D, Rouet F, Sorho S, Chaix ML, Eholié S, Menan H, Sauvageot D, Bissagnene E, Salamon R, Anglaret X, for the Trivacan ANR 1269 trial group. CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial . Lancet 2006;367:1981-9. [Ref.ID 77234]
5.Tiene citas relacionadas Cita con resumen
Deeks SG. The risk of treatment versus the risk of HIV replication. Lancet 2006;367:1955-6. [Ref.ID 77229]
6. Cita con resumen
Cissé B, Sokhna C, Boulanger D, Milet J, Bâ EH, Richardson K, Hallett R, Sutherland C, Simondon K, Simondon F, Alexander N, Gaye O, Targett G, Lines J, Greenwood B, Trape JF. Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial. Lancet 2006;367:659-67. [Ref.ID 76243]
7. Cita con resumen
West SK, Munoz B, Mkocha H, Holland MJ, Aguirre A, Solomon AW, Foster A, Bailey RL, Mabey D. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study. Lancet 2005;366:1296-300. [Ref.ID 75010]
8. Cita con resumen
Bryce J, Black RE, Walker N, Bhutta ZA, Lawn JE, Steketee RW. Can the world afford to save the lives of 6 million children each year?. Lancet 2005;365:2193-200. [Ref.ID 74222]
9.Tiene citas relacionadas Cita con resumen
Schellenberg D, Menendez C, Aponte JJ, Kahigwa E, Tanner M, Mshinda H, Alonso P. Intermittent preventive antimalarial treatment for Tanzanian infants: follow-up to age 2 years of a randomised placebo-controlled trial. Lancet 2005;365:1481-3. [Ref.ID 73620]
10.Tiene citas relacionadas Cita con resumen
Bates I. Presumptive malaria treatment in immunisation programmes. Lancet 2005;365:1443-4. [Ref.ID 73614]
11. Cita con resumen
12. Cita con resumen
D'Alessandro U, Coosemans M. Is it feasible to give insecticide-treated bednets free to pregnant women?. Lancet 2003;362:1515-6. [Ref.ID 68046]
13. Cita con resumen
Massaga JJ, Kitua AY, Lemnge MM, Akida JA, Malle LN, Ronn A M, Theander TG, Bygbjerg IC. Effect of intermittent treatment with amodiaquine on anaemia and malaria fevers in infants in Tanzania: a randomised placebo-controlled trial. Lancet 2003;361:1853-60. [Ref.ID 66135]
14. Cita con resumen
Maughan TS, James RD, Kerr DJ, Ledermann JA, Seymour MT, Topham C, McArdle C, Cain D, Stephens RJ, on behalf of the Medical Research Council Colorectal Cancer Group. Comparison of intermittent and continuous palliative chemotherapy for advanced colorectal cancer: a multicentre randomised trial. Lancet 2003;361:457-64. [Ref.ID 64964]
Lloyd I. Could less be more in the treatment of HIV?. Scrip Magazine 2000;94:7-10. [Ref.ID 53040]
16. Cita con resumen
Mavissakalian MR, Schmier JK, Flynn JA, Revicki D A. Cost effectiveness of acute imipramine therapy versus two imipramine maintenance treatment regimens for panic disorder. Pharmacoeconomics 2000;18:383-91. [Ref.ID 52996]
17.Tiene citas relacionadas
Gulick RM. Assessing the benefits of antiretroviral therapy. Ann Intern Med 2000;133:471-3. [Ref.ID 52641]
18.Tiene citas relacionadas
Kilby JM, Goepfert PA, Miller AP, Sillers M, Saag MS, Bucy RP. Recurrence of the acute HIV syndrome after interruption of antiretroviral therapy in a patient with chronic HIV infection: a case report. Ann Intern Med 2000;133:435-8. [Ref.ID 52637]
19.Tiene citas relacionadas
Colven R, Harrington RD, Spach DH, Cohen CJ, Hooton TM. Retroviral rebound syndrome after cessation of suppressive antiretroviral therapy in three patients with chronic HIV infection. Ann Intern Med 2000;133:430-4. [Ref.ID 52636]
Stalhammar NO, Carlsson J, Peacock R, Müller-Lissner S, Bigard MA, Porro G B, Ponce J, Hosie J, Scott M, Weir DG, Fulton C, Gillon K, Bardhan KD. Cost effectiveness of omeprazole and ranitidine as intermittent treatment of symptomatic gastro-oesophageal reflux disease. Pharmacoeconomics 1999;16:483-97. [Ref.ID 47576]
Seleccionar todas
 1 a 20 de 21 siguiente >>